AN2 Therapeutics, Inc. ANTX
- AN2-503321 — Solid Tumors Preclinical
- AN2-504661 — Hypophosphatasia Preclinical
ENPP1 (2 companies · 3 programs)
Companies with an active program directed at ENPP1.
RECURSION PHARMACEUTICALS, INC. RXRX
- Rec-102 — Hypophosphatasia Preclinical